Cumberland Pharmaceuticals Inc. (CPIX) financial statements (2021 and earlier)

Company profile

Business Address 2525 WEST END AVENUE
NASHVILLE,, TN 37203
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25283650505355
Cash and cash equivalents25282845353840
Short-term investments  85161515
Receivables121088766
Inventory, net of allowances, customer advances and progress billings119127546
Inventory119127546
Deferred tax assets   34
Other undisclosed current assets2333311
Total current assets:50505969666771
Noncurrent Assets
Operating lease, right-of-use asset2 
Property, plant and equipment1111011
Intangible assets, net (including goodwill)29323421222122
Goodwill111    
Intangible assets, net (excluding goodwill)28313421222122
Deferred costs332   2
Other noncurrent assets3332222
Deferred tax assets, net000311
Other undisclosed noncurrent assets91513   (2)
Total noncurrent assets:46545425282525
TOTAL ASSETS:9610511393939295
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25232818151215
Accounts payable1312119833
Accrued liabilities111117971011
Employee-related liabilities      1
Other liabilities      2
Other undisclosed current liabilities11    (3)
Total current liabilities:26242818151214
Noncurrent Liabilities
Long-term debt and lease obligation1619201042 
Long-term debt, excluding current maturities1519201042 
Operating lease, liability1 
Liabilities, other than long-term debt8992111
Other liabilities8992111
Other undisclosed noncurrent liabilities 2     
Total noncurrent liabilities:24292912531
Total liabilities:50535729201515
Stockholders' equity
Stockholders' equity attributable to parent, including:47515664737781
Retained earnings (accumulated deficit)(2)1512192019
Other undisclosed stockholders' equity attributable to parent49505152555762
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Total stockholders' equity:47515664737781
TOTAL LIABILITIES AND EQUITY:9610511393939295

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3748412211
Revenue, net41333437
Cost of revenue
(Cost of Goods and Services Sold)
(9)(9)(7)(7)(6)(5)(6)
Gross profit:293933(6)(4)(4)(5)
Operating expenses(35)(42)(41)(38)(29)(27)(28)
Other undisclosed operating income   40313337
Operating income (loss):(6)(4)(7)(4)(1)14
Nonoperating income
(Investment Income, Nonoperating)
0010000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (0)
Income (loss) from continuing operations before income taxes:(7)(4)(7)(4)(1)14
Income tax expense (benefit)(0)0(0)(4)0(1)(1)
Income (loss) from continuing operations:(7)(4)(7)(8)(1)12
Income from discontinued operations3      
Net income (loss):(3)(4)(7)(8)(1)12
Net income attributable to noncontrolling interest0000000
Net income (loss) available to common stockholders, diluted:(3)(4)(7)(8)(1)12

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(3)(4)(7)(8)(1)12
Other undisclosed comprehensive income 000000
Comprehensive income (loss):(3)(4)(7)(8)(1)12
Comprehensive income, net of tax, attributable to noncontrolling interest0000000
Other undisclosed comprehensive loss, net of tax, attributable to parent (0)(0)(0)(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(3)(4)(7)(8)(1)12

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: